3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
12
Non-Muscle Invasive Bladder Neoplasms
9
Carcinoma, Transitional Cell
7
Stomach Neoplasms
4
Anus Neoplasms
4
Pancreatic Neoplasms
3
Carcinoma, Hepatocellular
3
Peritoneal Neoplasms
2
Liver Neoplasms
2
Colorectal Neoplasms
2
Appendiceal Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Pseudomyxoma Peritonei
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Mycobacterium Infections
1
Gastrointestinal Neoplasms
1
Dermatitis
1
Carcinoma in Situ
1
Carcinoma
1
Anal Canal Carcinoma
1
Adenocarcinoma
1
Interventions
Etoposide
4
Cyclophosphamide
4
Vincristine
3
Specimen Handling
3
Prednisone
3
Magnetic Resonance Spectroscopy
3
Doxorubicin
3
Biopsy
3
fludarabine phosphate
2
cabozantinib
2
Whole-Body Irradiation
2
Watchful Waiting
2
Rituximab
2
Polymerase Chain Reaction
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Gene Expression Profiling
2
Fluorouracil
2
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
prednylidene
1
pembrolizumab
1
fludarabine
1
emvododstat
1
efineptakin alfa
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
HIV Infections
×
Mitomycin
×
Clear all
No trials found.